Synapse - Works

Results (4808)

Relationship between physician-adjudicated adverse events (AE) and patient-reported health-related quality of life (HRQoL) in a phase II clinical trial of patients (pts) with metastatic uveal melanoma (UM)

Meeting Abstract

Atkinson, T. M.; Hay, J. L.; Doyle, L. A.; Paucar, D.; Smith, S. C.; Li, Y. L.; Carvajal, R. D.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Reduction in late mortality among 5-year survivors of childhood cancer: A report from the Childhood Cancer Survivor Study (CCSS)

Meeting Abstract

Armstrong, G. T.; Yasui, Y.; Chen, Y.; Leisenring, W. M.; Gibson, T. M.; Mertens, A.; Stovall, M.; Hudson, M. M.; Oeffinger, K. C.; Bhatia, S.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center

Meeting Abstract

Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Comprehensive assessment of targetable alterations in lung adenocarcinoma samples with limited material using MSK-IMPACT, a clinical, hybrid capture-based, next-generation sequencing (NGS) assay

Meeting Abstract

Arcila, M. E.; Yu, H. A.; Drilon, A. E.; Riely, G. J.; Zehir, A.; Sadowska, J.; Hyman, D. M.; Kris, M. G.; Berger, M. F.; Ladanyi, M.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032

Meeting Abstract

Antonia, S. J.; Bendell, J. C.; Taylor, M. H.; Calvo, E.; Jaeger, D.; De Braud, F. G.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Molecular characterization of 350 hepatocellular carcinomas to identify biomarker aberrations with potential novel therapeutic options

Meeting Abstract

Ang, C.; Miura, J. T.; Gamblin, T. C.; Millis, S. Z.; Xiu, J.; Gatalica, Z.; Reddy, S. K.; Yee, N. S.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Computer automated bone scan index (BSI) as an analytically validated imaging biomarker to quantitate change in bone scan of patients with metastatic prostate cancer

Meeting Abstract

Anand, A.; Minarik, D.; Kaboteh, R.; Belal, S. L.; Reza, M.; Joseffson, A.; Edenbrandt, L.; Bjartell, A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Incidence and survival of gallbladder cancer over three decades: A SEER database study

Meeting Abstract

Ali, A.; Pendharkar, S.; Ali, R.; Chichra, A.; Pendharkar, D.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Phase II trial of trametinib in combination with the AKT inhibitor GSK 2141795 in BRAF wild-type melanoma

Meeting Abstract

Algazi, A. P.; Muthukumar, A. H.; O'Brien, K.; Lencioni, A.; Tsai, K. K.; Kadafour, M.; Chapman, P. B.; Daud, A.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

A randomized phase II study of paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus and ixabepilone/carboplatin/bevacizumab as initial therapy for measurable stage III or IVA, stage IVB or recurrent endometrial cancer, GOG-86P

Meeting Abstract

Aghajanian, C.; Filiaci, V. L.; Dizon, D. S.; Carlson, J.; Powell, M. A.; Secord, A. A.; Tewari, K. S.; Bender, D.; O'Malley, D. M.; Stuckey, A.; more...
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save